Business
The drugstore chain and tech-enabled digital health platform will support providers in helping their patients transition to home after being discharged from the hospital.
Finalization of the deal is contingent upon approvals by state and regulatory authorities.
The company's computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.
It was initially launched to help dispel the infodemic that ensued during the recent pandemic.
Also, DeepTek and Alveofit obtained respective regulatory approvals in Thailand and the United States.
Prior authorization company Myndshft unites with philanthropic aid platform Atlas Health, and women's care company ProgenyHealth and insurer Community Health Choice also join forces.
The algorithm helps predict missed appointments, failure to schedule follow-up visits and late arrivals.
The deal comes less than a month after the company's plan to combine with digital neurotherapy company MindMaze fell through.
Also, Abbott has launched its vertigo support app in India.
Medication management platform PatchRx and brain health company Neurpowyzer also garnered investment.